Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Novel Staphylococcus aureus phages and composition thereof, and applications of composition

A staphylococcus, golden yellow technology, applied in the field of microorganisms, can solve problems such as the bactericidal ability of a single phage

Active Publication Date: 2018-08-03
PHAGELUX (NANJING) BIO-TECH CO LTD
View PDF3 Cites 22 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, most of the Staphylococcus aureus phage literature is limited to the research on the bactericidal ability of a single phage (Wang, Z.F., et al., SLPW: A Virulent Bacteriophage Targeting Methicillin-Resistant Staphylococcus aureus In vitro and In vivo. Frontiers in Microbiology, 2016.7: p.10.; Jia, H.Y., et al., Characterization and completegenome sequence analysis of Staphylococcus aureus bacteriophage JS01. VirusGenes, 2015.50(2): p.345-348. Jiangnan University, a phage of Staphylococcus aureus and its application, application number CN201110380587), but there are few reports on the characteristics of the cocktail mixture composed of several phages

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel Staphylococcus aureus phages and composition thereof, and applications of composition
  • Novel Staphylococcus aureus phages and composition thereof, and applications of composition
  • Novel Staphylococcus aureus phages and composition thereof, and applications of composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0048] Example 1: Isolation, preparation and purification of phage

[0049] In the present invention, the source samples of brachyphage BP-13, Staphylococcus aureus BP-13A, brachyphage BP-14 and brachyphage AHJD-like phage genus BP-39 were collected from the sewage treatment plant in Montreal, Canada, and passed through double-layer filter paper. After filtration, centrifuge at low speed and normal temperature, and then filter the supernatant with a 0.22 μm filter membrane.

[0050] Isolation of phage: Take 10mL of filtered supernatant, add it to 10mL 2 times TSB medium, add 1mL of phage host bacteria logarithmic phase bacteria liquid at the same time, place it at 37°C for 16h, take the above culture, and put it under the condition of 8000rpm Centrifuge for 10 min, filter the supernatant with a 0.22 μm filter membrane, and set aside. Take 0.5mL of phage host bacteria logarithmic phase bacteria liquid, add 5mL, 40 ℃ semi-solid TSB medium, mix well, pour on the TSA plate, and p...

Embodiment 2

[0052] Embodiment 2: Electron microscope observation of phage

[0053] Take the supernatant of each phage culture obtained in Example 1 for electron microscope observation: take 20 μ L of sample and drop it on the copper grid, wait for its natural precipitation for 15 minutes, absorb excess liquid from the side with filter paper, add 1 drop of 2% phosphotungstic acid (PTA ) on a copper grid, dyed for 10 minutes, sucked the dye solution from the side with filter paper, and observed with an electron microscope after drying: the results are as follows: figure 1 As shown, the BP-13 phage morphology was found to have a regular polyhedral head structure and a shorter tail, the head diameter was about 150nm, and the tail length was about 10nm ( figure 1 -A); The morphology of BP-13A bacteriophage was found to have a regular polyhedral head structure and a shorter tail, the diameter of the head was about 100nm, the length of the tail was about 10nm, and the end of the tail had six sho...

Embodiment 3

[0054] Example 3: Extraction and sequencing of phage genome

[0055] Take 100 mL of each phage prepared in Example 1, add DNaseI and RNaseA at a final concentration of 1 μg / mL, incubate at 37°C for 60 min, add 5.84 g NaCl (final concentration 1 mol / L), dissolve and place in an ice bath for 1 h. Centrifuge at 11,000 rpm for 10 min at 4°C, and transfer the supernatant to a new centrifuge tube. Add solid PEG8000 (final concentration 10%, that is, add 10 g to 100 mL), and after complete dissolution, ice bath for at least 1 h. Centrifuge at 11,000 rpm for 20 min at 4°C, and resuspend the pellet with a small amount of SM solution. Add an equal volume of chloroform and isoamyl alcohol for extraction, shake gently for 30 s, centrifuge at 8000 rpm for 1 min, absorb the supernatant, and repeat the extraction until clarification. Add DNase I and RNase A again to a final concentration of 1 μg / mL, and react at 37°C for 30-60 minutes. Add EDTA to a final concentration of 20 mmol / L (that ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to View More

Abstract

The invention relates to the field of biology, particularly to novel Staphylococcus aureus phages and a composition thereof, and applications of the composition, and provides 4 Staphylococcus aureus phages such as Podoviridae sp .BP-13 with the preservation number of CCTCC NO:M2015142, Staphylococcus aureus phage BP-13A with the preservation number of CCTCC NO:M2016535, Podoviridae sp .BP-14 withthe preservation number of CCTCC NO:M2015143, and Podoviridae picovirinae Ahjdlikevirus BP-39 with the preservation number of CCTCC NO:M2015144. According to the present invention, the four phages arethe strict potent phages, can effectively kill various types of Staphylococcus aureus such as MRSA, MSSA, BORSA and the like, have wide host ranges, and have no toxic effect on normal microbial flora, and the DNA of the phages cannot encode virulence genes, such that the Staphylococcus aureus phages can be used for preventing or treating human and animal bacterial infections caused by Staphylococcus aureus, can provide excellent strain resources for the development of novel antibacterial preparations, and have good application development prospects; and the host range and the antibacterial efficiency of the cocktail mixture of the present invention are further greatly improved.

Description

technical field [0001] The invention belongs to the technical field of microbes, and in particular relates to novel staphylococcus aureus phages, their composition, their preparation method and application. Background technique [0002] Staphylococcus aureus (Staphylococcus aureus) is an important zoonotic pathogen, which widely exists in nature and has a wide range of infection and strong adaptability. It can cause wound infection, endocarditis, osteomyelitis, and toxic shock Syndrome and other diseases, resulting in a mortality rate ranging from 11% to 48%. Methicillin-sensitive Staphylococcus aureus (MSSA) can be killed by penicillin and methicillin, but more than half of Staphylococcus aureus in the United States is now resistant to penicillin, methicillin, tetracycline, and erythromycin, and methicillin-resistant Staphylococcus aureus (MRSA) is the most prevalent pathogen in hospitals and is resistant to all β-lactam antibiotics except the novel cephalosporins. In add...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N7/00A61K35/76A61P31/04A61P17/02A61P15/14
CPCA61K35/76C12N7/00A61P31/04A61P17/02A61P15/14C12N2795/10221C12N2795/10232Y02A50/30
Inventor 费文斌肖逍苏胜兵乔欢丛郁徐旭凌丁良许文建周思翔熊剑胜沈婵娟王艳赵伟王卫斌霍茨蒙德·曼德维尔马克·恩格尔
Owner PHAGELUX (NANJING) BIO-TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com